Imashuku S - Search Results

1

Complete response of adult-onset CNS Langerhans cell histiocytosis documented on 18F-FDG PET/CT.

Kruljac I, Balenović A, Gaćina P, Imashuku S, Vrkljan M. Kruljac I, et al. Among authors: imashuku s. Clin Nucl Med. 2015 Dec;40(12):981-2. doi: 10.1097/RLU.0000000000000994. Clin Nucl Med. 2015. PMID: 26402130

2

Treatment of neurodegenerative CNS disease in Langerhans cell histiocytosis with a combination of intravenous immunoglobulin and chemotherapy.

Imashuku S, Okazaki N', Nakayama M, Fujita N, Fukuyama T, Koike K, Minato T, Kobayashi R, Morimoto A; Japan LCH Study Group. Imashuku S, et al. Pediatr Blood Cancer. 2008 Feb;50(2):308-11. doi: 10.1002/pbc.21259. Pediatr Blood Cancer. 2008. PMID: 17458874

3

Neurodegenerative central nervous system disease as late sequelae of Langerhans cell histiocytosis. Report from the Japan LCH Study Group.

Imashuku S, Shioda Y, Kobayashi R, Hosoi G, Fujino H, Seto S, Wakita H, Oka A, Okazaki N, Fujita N, Minato T, Koike K, Tsunematsu Y, Morimoto A; Japan LCH Study Group (JLSG). Imashuku S, et al. Haematologica. 2008 Apr;93(4):615-8. doi: 10.3324/haematol.11827. Epub 2008 Feb 20. Haematologica. 2008. PMID: 18287136 Free article.

4

High dose immunoglobulin (IVIG) may reduce the incidence of Langerhans cell histiocytosis (LCH)-associated central nervous system involvement.

Imashuku S. Imashuku S. CNS Neurol Disord Drug Targets. 2009 Nov;8(5):380-6. doi: 10.2174/187152709789541970. CNS Neurol Disord Drug Targets. 2009. PMID: 19702569 Review.

5

Treatment of patients with hypothalamic-pituitary lesions as adult-onset Langerhans cell histiocytosis.

Imashuku S, Kudo N, Kaneda S, Kuroda H, Shiwa T, Hiraiwa T, Inagaki A, Morimoto A. Imashuku S, et al. Int J Hematol. 2011 Dec;94(6):556-60. doi: 10.1007/s12185-011-0955-z. Epub 2011 Oct 21. Int J Hematol. 2011. PMID: 22015494

6

Strategies for the Prevention of Central Nervous System Complications in Patients with Langerhans Cell Histiocytosis: The Problem of Neurodegenerative Syndrome.

Imashuku S, Arceci RJ. Imashuku S, et al. Hematol Oncol Clin North Am. 2015 Oct;29(5):875-93. doi: 10.1016/j.hoc.2015.06.006. Epub 2015 Aug 25. Hematol Oncol Clin North Am. 2015. PMID: 26461148 Review.

7

Hematopoietic stem cell transplantation (HSCT) for Langerhans cell histiocytosis (LCH) in Japan.

Kinugawa N, Imashuku S, Hirota Y, Yamada K, Yamamoto A, Akazai A, Oda M, Miura N, Kakuta H, Sato T, Endo M, Takano T. Kinugawa N, et al. Among authors: imashuku s. Bone Marrow Transplant. 1999 Oct;24(8):935-8. doi: 10.1038/sj.bmt.1702001. Bone Marrow Transplant. 1999. PMID: 10516710

8

Successful treatment of congenital systemic juvenile xanthogranuloma with Langerhans cell histiocytosis-based chemotherapy.

Nakatani T, Morimoto A, Kato R, Tokuda S, Sugimoto T, Tokiwa K, Tsuchihashi Y, Imashuku S. Nakatani T, et al. Among authors: imashuku s. J Pediatr Hematol Oncol. 2004 Jun;26(6):371-4. doi: 10.1097/00043426-200406000-00007. J Pediatr Hematol Oncol. 2004. PMID: 15167350

9

Mondini dysplasia and recurrent bacterial meningitis in a girl with relapsing Langerhans cell histiocytosis.

Kitazawa K, Matsumoto M, Senda M, Honda A, Morimoto N, Kawashiro N, Imashuku S. Kitazawa K, et al. Among authors: imashuku s. Pediatr Blood Cancer. 2004 Jul;43(1):85-7. doi: 10.1002/pbc.20057. Pediatr Blood Cancer. 2004. PMID: 15170897

10

Cerebellar ataxia in pediatric patients with Langerhans cell histiocytosis.

Imashuku S, Ishida S, Koike K, Ichikawa M, Minato T, Suzuki Y, Kobayashi R, Morimoto A; Japan LCH Study Group. Imashuku S, et al. J Pediatr Hematol Oncol. 2004 Nov;26(11):735-9. doi: 10.1097/00043426-200411000-00009. J Pediatr Hematol Oncol. 2004. PMID: 15543008

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters